Common-Size Income Statement
Quarterly Data
Paying user area
Try for free
AbbVie Inc. pages available for free this week:
- Common-Size Balance Sheet: Assets
- Enterprise Value to FCFF (EV/FCFF)
- Return on Equity (ROE) since 2012
- Return on Assets (ROA) since 2012
- Debt to Equity since 2012
- Price to Operating Profit (P/OP) since 2012
- Price to Book Value (P/BV) since 2012
- Price to Sales (P/S) since 2012
- Analysis of Revenues
- Analysis of Debt
The data is hidden behind: . Unhide it.
Get full access to the entire website from $10.42/mo, or
get 1-month access to AbbVie Inc. for $24.99.
This is a one-time payment. There is no automatic renewal.
We accept:
AbbVie Inc., common-size consolidated income statement (quarterly data)
Based on: 10-Q (reporting date: 2025-09-30), 10-Q (reporting date: 2025-06-30), 10-Q (reporting date: 2025-03-31), 10-K (reporting date: 2024-12-31), 10-Q (reporting date: 2024-09-30), 10-Q (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-K (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31).
- Gross Margin and Cost of Products Sold
- The gross margin as a percentage of net revenues experienced notable fluctuations throughout the periods, ranging roughly between 53.44% and 77.47%. There is an observable decline in gross margin during mid-2023, coinciding with spikes in the cost of products sold, which in some quarters reached as high as -46.56% of net revenues. Following this period, the gross margin stabilized again around 66% to 71%, indicating some recovery in cost management or pricing structure.
- Operating Expenses
- Selling, general, and administrative expenses remained relatively steady with variations mostly between -19.67% and -37.11% of net revenues. A peak in SG&A expense was recorded around mid-2022 at -37.11%. Research and development expenses showed a downward trend overall, initially decreasing from around -16.00% in early 2020 to levels closer to -10.90% by late 2022, albeit with a notable spike to -18.75% in early 2023. Acquired in-process research and development (IPR&D) and milestones fluctuated considerably, with increased costs observed in late 2024 and 2025, marked by negative percentages reaching up to -16.99%.
- Operating Earnings
- Operating earnings as a percentage of net revenues varied significantly, with initial values near 41.8% dropping to around 7.21% mid-2020, followed by a general recovery and stabilization in the range of 22% to 36% from late 2020 through 2022. After some volatility, operating earnings declined sharply to -9.87% in early 2025 but rebounded again later in 2025. This variability indicates some operational challenges and volatile profitability periods.
- Interest Expense and Other Income (Expense)
- Interest expense showed a gradual improvement over the analyzed periods, decreasing from nearly -4.97% to around -2.64% of net revenues at its lowest point. Other income and expense items showed considerable volatility, with some quarters evidencing significant negative impacts (e.g., -33.37% in late 2020), which likely contributed to fluctuations in pre-tax earnings and net results.
- Earnings before Income Tax and Net Earnings
- Earnings before income tax were quite volatile, with significant swings from positive values as high as about 36.41% down to negative double digits, especially in certain quarters of 2020 and 2025. Net earnings followed a similar pattern, with positive margins generally above 10% but with periods of decline to near breakeven or slight losses (notably -7.09% and -0.15% in some quarters). The net earnings attributable to the company mirrored these trends closely, indicating consistency in reporting attribution.
- Income Taxes
- Income tax expense as a percentage of net revenues fluctuated without a clear trend, often ranging between approximately -5.35% and positive values exceeding 14%. Positive spikes, such as 14.87% in early 2025, suggest periods of tax charges impacting earnings substantially.
- Overall Financial Performance Insights
- The data depicts a company experiencing significant quarter-to-quarter variability in profitability and operating efficiency. Periods of high cost of goods sold and increased operating expenses particularly influenced margins. Despite these fluctuations, the company maintains a gross margin typically above 60%, demonstrating resilient core profitability. However, spikes in restructuring or milestone payments and other one-off items contributed to operating and net earnings volatility. Interest expense improved moderately over time, indicating potential debt management efforts. Earnings before taxes and net earnings showed vulnerability to these operational swings, reflecting sensitivity to cost management and external financial factors such as exchange rates and other income components.